Elecsys® GAAD clinical trials

Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC

This study looks at a new test called Elecsys® GAAD to help doctors find liver cancer (hepatocellular carcinoma) earlier in people with liver scarring (cirrhosis). The aim is to see if this new test can improve current screening methods and help patients get treatment sooner.